Reuters logo
BRIEF-Cadila Healthcare says ‍Zydus gets U.S.FDA nod for drug to treat skin conditions‍​
October 30, 2017 / 6:14 AM / 23 days ago

BRIEF-Cadila Healthcare says ‍Zydus gets U.S.FDA nod for drug to treat skin conditions‍​

Oct 30 (Reuters) - Cadila Healthcare Ltd:

* Says ‍Zydus receives final approval from USFDA for Clobetasol Propionate Ointment USP

* Says will be manufactured in co’s topical manufacturing facilty at Ahmedabad​

* Says drug is indicated to treat variety of skin conditions‍​ Source text: bit.ly/2z3qo5l Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below